Depression   

How do you frame lithium's risk-benefit profile compared with other mood stabilizers or atypical antipsychotics? How do you address patient fears abou...

How do you frame sleep protection as part of depression treatment without undermining breastfeeding goals? How do you navigate guilt, cultural expecta...

How do you educate patients about the role exercise may play in depression treatment? What type, frequency, and intensity of exercise do you recommend...

What clinical criteria (e.g., number of failed antidepressant trials, comorbidities, acuity) prompt you to refer for TMS or esketamine? How do you cou...

What factors guide your assessment of the risk for antidepressant-induced hypomania for mood destabilization? Which antidepressants do you find safest...

What clinical features or patient characteristics lead you to consider an MAOI? How do concerns about safety, dietary restrictions, drug interactions,...

What clinical factors influence your decision? Are there specific practice settings or insurance considerations that push you toward one option over t...

How do you determine which medications are most likely to require prior authorization? How do you streamline the prior authorization process and fit i...

What monitoring strategies (e.g., sodium checks, fluid restriction, dose adjustments) have you found most practical in these cases? In what situations...

How do you approach shared decision-making when patients express hesitancy about medication exposure in utero? What is your approach when a patient is...

In your clinical practice, have you noticed whether concurrent pharmacotherapy improves the durability of ketamine’s effects? Which medications ...

If yes, what kind of training did you pursue? How do you see psilocybin fitting into your practice (or not)? Are there particular skills you feel woul...

When do you consider referring a patient to a clinical trial? How have patients responded to being offered trial participation? What has your experien...